UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Trial Details

NCT ID

NCT06245746

Phase

PHASE1

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Status

RECRUITING

Cancer Type

Leukemia

Interventions

• umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo)

Locations (sample)

• Wuhan, Hubei, China|30.58333,114.26667

Key Eligibility Criteria

• Aged between 18 and 60 years old;
• Acute myeloid leukemia (AML, AML subtype M3 excluded) diagnosed according to the 2022 revision to the World Health Organization classification of m…
• The participant or his/her legal guardian is adequately informed of the nature and risks of the study, voluntarily participates in the study with s…
• Male or female;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.